OncoZenge AB (publ) (STO:ONCOZ)

OncoZenge AB Revenue

OncoZenge AB had revenue of 5.96M SEK in the quarter ending June 30, 2026, with 4,996.58% growth. This brings the company's revenue in the last twelve months to 5.97M, up 114.78% year-over-year. In the year 2025, OncoZenge AB had annual revenue of 2.78M with 278,300.00% growth. That makes OncoZenge AB the 44,301st largest company in the world by revenue and 692nd in Sweden.

• Revenue (ttm): 5.97M
• Revenue Growth: +114.78%
• P/S Ratio: 16.87
• Revenue / Employee: 5.97M
• Employees: 1
• Market Cap: 99.36M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.78M	2.78M	278,300.00%
Dec 31, 2024	1.00K	-2.00K	-66.67%
Dec 31, 2023	3.00K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 12, 2026

Data Sources Report a data error